Datum: 1.10.2021
Summary:
A Danish biotechnology SME is developing a novel software for recombinant antibody-developers, giving them an easy-to-use tool to predict which antibodies are most likely to succeed during production. In the collaboration proposed, the partner will have free access to the solution during the closed beta in return for feedback on the use and performance. The company offers technical cooperation and commercial agreements with technical assistance.
Reference: TODK20210722001
Country: Denmark
Submitted: 1. 10. 2021
Keywords
Technology: Artificial Intelligence (AI), Data Processing / Data Interchange, Middleware, Medical Technology / Biomedical Engineering, Biochemistry / Biophysics, Protein Engineering.
Market: Monoclonal Antibodies and Hybridomas, Biochemistry / Biophysics, Enzymology/Protein Engineering/Fermentation.
NACE: -
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnologický portál - Vše o biotechnologiích na jednom místě.
ISSN 1802-2685
Tvorba webových stránek: CREOS CZ
© 2006 - 2024 Jihočeská agentura pro podporu inovačního podnikání o.p.s.
Zajímavé články s biotechnologickým obsahem:
ZamÄ›stnanci - Jak hledat a jak zĂskat dobrĂ© zamÄ›stnance?
Enzyme biotechnology - enzymes, biotech
VakcĂna ve spreji zatoÄŤĂ s ĂşpornĂ˝mi infekcemi moÄŤovĂ˝ch cest
Cetch-Pure je prvnà nebuněčný systém, který funkčně spojuje genetiku a metabolismus